Current Treatment Options in Oncology

期刊全称Current Treatment Options in Oncology
期刊缩写CURR TREAT OPTION ON
涉及主题医学内科学生物遗传学病理肿瘤科外科癌症放射科免疫学化疗化学生物化学放射治疗生物信息学癌症研究疾病临床试验心理学重症监护医学
期刊介绍

This journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to cancer treatment. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as endocrine tumors, lymphomas, neuro-oncology, and cancers of the breast, head and neck, lung, skin, gastrointestinal tract, and genitourinary region. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known oncologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.

期刊ISSNprint: 1527-2729
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
3.84.35.085.0363.93.8513.5622.82
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量511101171241121079181756360485144
被引量16044071447941194025331725322165206717381582157816061481
h-Index48
自引率0.00%
涉及的研究领域ONCOLOGY-
中科院2025年分区 ?
大类小类TOP期刊综述期刊
2区2区 肿瘤学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
ONCOLOGYSCIEQ177/326

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
ONCOLOGYSCIEQ3179/326
期刊主页https://www.springer.com/11864https://www.springer.com/journal/11864
投稿网址https://www.editorialmanager.com/ctoo
出版商Springer US
出版国家(地区)US
出版语言English
出版周期Bimonthly
每年出版文章数114
Gold OA文章占比20.75%
原创研究文献占比
(排除综述)
0.00%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1527-2729%5BISSN%5D
平均审稿周期>12周,或约稿
平均录用比例较易
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈